Skip to content

Clinical trials

Terminated Schizophrenia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Terminated Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20113
20121
20152
20161
20177
20184
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hôpital le Vinatier6
University Hospital, Strasbourg, France6
Boehringer Ingelheim2
Denovo Biopharma LLC2
Amgen1
Assistance Publique - Hôpitaux de Paris1
Bristol-Myers Squibb1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier Universitaire de Saint Etienne1
GCS CIPS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia25
Metabolic Syndrome2
Psychotic Disorders2
Agnosia1
Bipolar Disorder1
Marijuana Abuse1
Obesity1
Pain1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.